News Markets & Companies
Evonik increases EBITDA by 24 % in the second quarter – outlook for 2026 raised
The Essen (Germany)-based speciality chemicals company reports impressive results for the second quarter of 2026, with a 24 % increase in EBITDA and a significantly raised forecast for the financial year 2026. Supply chain disruptions outside Europe and increased sales prices are driving the development.
Evonik achieved exceptional results in the second quarter of 2026. Adjusted EBITDA rose by 24 % compared to the same period of the previous year, reaching 630 million EUR. Key drivers were increased sales volumes and prices, particularly due to supply chain disruptions among Asian competitors caused by the security situation in the Middle East. Revenue increased by 11 % over the same period.
The chemicals company had already forecasted a range of 600 to 650 million EUR for the second quarter in June and significantly raised its expectations for the year 2026. The group now anticipates adjusted EBITDA between 2.0 and 2.2 billion EUR – a notable jump from the previous target range of 1.7 to 2.0 billion EUR. By comparison, the figure for 2025 was approximately 1.9 billion EUR.
Efficiency programme and job cuts
To remain competitive in the long term, Evonik is extending its efficiency programme “Evonik Tailor Made”. A total of 2,800 positions are to be cut by 2026, followed by an additional 3,200 jobs between 2027 and 2029. Since the beginning of 2026, the workforce has already been reduced by 700. The aim is to secure the company’s financial stability through targeted savings and efficiency measures.
Free cash flow also showed positive development in the second quarter. At 49 million EUR, it was significantly better than in the previous year’s quarter (minus 211 million EUR).
